Clinical Trials Browser

Not yet recruiting × Colonic Neoplasms × XELOX × Clear all

NCT07156682 2025-09-05

QL1706 Plus XELOX as Neoadjuvant Therapy for MSS/pMMR Clinical Stage III Colon Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Colonic Neoplasms